Jens Lindberg

Jens Lindberg has 25 years of experience from pharmaceutical industry spanning global and local responsibilities. He has led product strategy development for late stage compounds preparing for regulatory approval and commercialization as well as execution of launch for multiple compounds in specialty care. His primary area of focus in the past 10 years is in the field of Oncology and his experience also includes interim CEO role for Sedana Medical AB and Director Investor Relations at AstraZeneca.